Company / PP&E (Net)
PAVmed Inc. PP&E (Net) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$77.0K
FY2025
5-year range
$77.0K / $2.5M
FY2021-FY2025
Trend
-49.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has declined for 3 consecutive years, from $2M in FY2022 to $77,000 in FY2025.
Based on SEC 10-K filings.
$77,000 in FY2025 with a 3-year CAGR of -68.4%.
Declined from $2M to $77,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -68.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- PAVmed Inc.'s pp&e (net) has declined for 3 consecutive years.
- 3-year CAGR of -68.4%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 49.0% year-over-year.
- Peak pp&e (net) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $77.0K | -49.0% |
| FY2024 | $151.0K | -91.5% |
| FY2023 | $1.8M | -27.3% |
| FY2022 | $2.5M | +54.6% |
| FY2021 | $1.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026